INTRODUCTION AND OBJECTIVES: The most common lifestyle preventative treatment of stone disease is increasing fluid intake. However, many patients experience lower urinary tract symptoms (LUTS) that may impair their ability to increase fluid intake. The objective of this study is to determine if there is a correlation between International Prostate Symptom Scores (IPSS) and 24-hour urine collection volumes.
METHODS: We retrospectively reviewed all kidney stone patients over a 2 year period who were given IPSS questionnaires at the time of their initial consultation, and their subsequent 24-hr urine collections. Exclusion criteria included symptomatic stone or urinary tract infection at time of IPSS completion, inadequate 24-hour collection, or incomplete IPSS questionnaire. RESULTS: Overall, 131 patients met inclusion criteria, with a mean age of 53 years. Stratification by IPSS score into mild (0-7), moderate (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) , and severe (20-35) yielded groups of N¼96, 28, and 7, respectively. Linear regression modelling did not reveal a correlation between IPSS score and volume (p¼0.1). There was no difference between urine volumes in the mild, moderate and severe groups (p¼0.07). However, when comparing those with severe LUTS to the rest of the population, they showed significantly lower daily urine volumes (mean 1.4 L/day vs 2.0 L/day; p¼0.02). When patients with low urine outputs (1 L/day) (N¼1F:9M, mean age 54 years old), were compared to those adequate urine volumes (2 L/day) (N¼6F:59M, mean age 52 years old), a significantly higher overall IPSS score was noted (11.7 vs. 6.1; p¼0.04). Low output patients reported significantly higher scores on the questions related to incomplete emptying (1.8 vs. 0.7; p¼0.03), intermittency (1.7 vs. 0.6; p¼0.01), and straining (1.8 vs. 0.4; p¼0.002).
CONCLUSIONS: This study is the first to examine the correlation between IPSS score and 24-hour urine volume. Though our data does not show a linear relationship between urine output and IPSS; those with lower urine volumes (1 L/day) have significantly worse self reported voiding symptoms when compared to those with adequate volumes (2 L/day) for stone prevention. 
Source of

INTRODUCTION AND OBJECTIVES:
Patients often express concerns about the burden of chronic medication use for stone prevention despite its association with decreased stone recurrence. Fatigue and sexual side effects are among such concerns of patients starting thiazide diuretics. However, it is unknown how the use of thiazides affects the health-related quality of life (HRQOL) of stone formers. We evaluated the effect of thiazides on patients' stone-related HRQOL.
METHODS: Utilizing the previously validated Wisconsin Stone QOL questionnaire (WISQOL), we analyzed cross-sectional data from patients both new to and established in stone prevention who were enrolled at sites participating in the North American Stone Quality of Life Consortium. We compared HRQOL in the domains of social impact, emotional impact, disease impact, and vitality in patients prescribed thiazides against those not using student's t-test. We performed multivariate linear regression controlling for age, gender, BMI, and number of stone events to confirm the significance of any differences. Additionally, we assessed with univariate and multivariate logistic regression the likelihood of complaints of fatigue and reduced sexual interest/activity between those prescribed and not prescribed thiazides.
RESULTS: 1511 stone formers were included (787 M, 724 F), of whom 207 were on a thiazide at study enrollment. Patients prescribed a thiazide had significantly higher scores (better HRQOL) in each domain compared to those not prescribed a thiazide. These differences maintained significance with multivariate analysis (mean domain scores higher by 1.9, 2.3, 2.1, 1.0 points, respectively, all p<0.01). Patients prescribed thiazides were less likely than those not prescribed to report any fatigue in the last 4 weeks (59% vs 68%, p¼0.008). Those on thiazides were less likely to report reduced sexual interest/activity (24% vs 31%, p¼0.02). On multivariate logistic regression, patients on thiazides were overall 32% less likely to report fatigue, p¼0.02, and 33% less likely to report reduced sexual interest/activity, p¼0.026, when controlling for the aforementioned factors.
CONCLUSIONS: Patients prescribed thiazide diuretics for stone prevention demonstrated better HRQOL compared to patients not prescribed one. Specifically, thiazide use was not associated with fatigue or reduced sexual interest/activity. These findings may provide reassurance to patients being counseled on starting thiazides for medical management of stones. METHODS: Utilizing the previously validated Wisconsin Stone-QOL questionnaire (WISQOL), a kidney stone-specific instrument, we analyzed cross-sectional data from patients both new to and already established in stone prevention who were enrolled at sites participating in the North American Stone Quality of Life Consortium. We compared HRQOL in the WISQOL domains of social impact, emotional impact, disease impact, and vitality between patients prescribed potassium citrate and those not. In addition to student's t-test, multivariate linear regression controlling for age, gender, BMI, and number of stone events was performed to determine the strength of any differences found. Additionally, univariate and multivariate logistic regression were used to assess the likelihood of complaints of nausea and stomach upset or cramps between those prescribed and not prescribed potassium citrate.
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RESULTS: 1511 stone formers were included (787 male, 724 female), of whom 258 were on potassium citrate at study enrollment. Patients prescribed potassium citrate scored significantly higher (better e1212 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 HRQOL) in each of the domains. With multivariate analysis, these differences maintained their significance (mean domain scores were higher by 2.5, 2.8, 2.8, 1.3 points, respectively, all p<0.0001). In itemlevel analysis, patients prescribed potassium citrate were less likely than those not prescribed it to report any nausea, stomach upset or cramps (43% vs 55%, p<0.001). Multivariate logistic regression showed a 40% lower likelihood of having GI complaints among patients prescribed potassium citrate, p¼0.001, when controlling for the aforementioned factors. CONCLUSIONS: Among chronic stone forming patients, the use of potassium citrate is associated with higher HRQOL across all domains of the WISQOL. Those prescribed potassium citrate appear less likely to endorse GI complaints compared to those not. These findings may be useful when encouraging patients to consider initiating potassium citrate therapy.
Source of Funding: None
MP90-08 VARIABILITY IN STONE COMPOSITION AND METABOLIC EVALUATION BETWEEN KIDNEYS IN PATIENTS WITH BILATERAL NEPHROLITHIASIS
Marcelino Rivera*, Indianapolis, IN; Michael Borofsky, Minneapolis, MN; Suzanne Kissel, Indianapolis, IN; Casey Dauw, Ann Arbor, MI; Nadya York, Amy Krambeck, James Lingeman, Indianapolis, IN INTRODUCTION AND OBJECTIVES: Current American Urological Association (AUA) guidelines do not discuss recommendations in obtaining a stone analysis when a bilateral stone procedure is performed. To date, there is a limited amount of data surrounding discordant stone analysis when performing a simultaneous bilateral stone procedure. Stone analysis results, as well as 24-hour urinalysis are utilized for the medical management of stone disease and could possibly be misrepresented if conflicting stone analysis results were present. Therefore, we aim to describe the rate of discordant stone analysis results in patients undergoing ureteroscopy.
METHODS: A retrospective chart review was performed for all patients undergoing bilateral ureteroscopy with stone removal by a single surgeon at a single hospital between 2013 and 2016. All stones were analyzed at a single stone analysis laboratory using Fourier transform infrared spectroscopy (Beck labs, Indianapolis IN). Stones were then classified unilaterally based upon the dominant present (>50%). The only exception was for brushite where the presence of any brushite led to classification as a brushite stone former. 24-hour urinalysis results were reviewed and statistical analysis performed comparing discordant and concordant patient populations, assessing significant differences that would influence clinical management.
RESULTS: We identified 89 patients (178 renal units) who had bilateral stones removed at the time of ureteroscopy. The majority of stones were classified as calcium oxalate (CaOx) (59.4%) followed by CaP (30.6%), uric acid (UA) (3.9%), brushite (3.9%) and cystine (2.2%). Discrepancies in stone classifications were present 22% of the time. Evaluation of 24-hour urinalysis results demonstrated striking differences between those with conflicting and similar stone analysis results. Those patients with CaOx:CaP stone discordance compared to CaOx:CaOx concordant stone formers were more likely to have an elevated pH (p<0.001), calcium phosphate supersaturation (p<0.01) and lower uric acid supersaturation (p¼0.02).
CONCLUSIONS: Discrepancies in stone classifications are common in patients with bilateral stone disease. When metabolic evaluation was performed in these patients there were significant differences between discordant and concordant groups, especially CaOx only and CaOx:CaP stone formers. Thus, a single stone analysis in the setting of bilateral stone disease is insufficient and may lead to mismanagement when it is utilized in addition to 24-hour urinalysis results.
Source of Funding: None
MP90-09 THE METABOLIC SYNDROME AND ITS IMPACT ON CALCIUM OXALATE STONE TYPE Egor Parkhomenko*, Kathleen Kan, Timothy Tran, Julie Thai, Kyle Blum, Mantu Gupta, NY, NY INTRODUCTION AND OBJECTIVES: The metabolic syndrome plays an important role in lithogenesis of calcium oxalate stones, but to our knowledge no study has clinically correlated metabolic factors that influence stone subtype. It has been indicated that calcium oxalate monohydrate (COM) stones are more likely of tubular origin as secondary deposits onto calcium apatite whereas calcium oxalate dihydrate (COD) stones are more likely to form in solution. We sought to perform a comprehensive analysis of metabolic and clinical factors in patients who make predominantly one type of calcium oxalate stone.
METHODS: From our prospectively maintained database of 1049 kidney stone formers between 01/2014 -06/2016, we identified 95 patients with comprehensive medical records including stone analysis who had predominantly (80%) COM (75 pts) or COD (20 pts) composition. Another 27 patients had mixed COM and COD stones (<80% of one subtype). Clinical, demographic and laboratory parameters were compared between (>80%) COM or COD stones.
RESULTS: There were no differences in age, gender or BMI between the COM and COD patients. COM patients were more likely to be hypertensive (46.7% vs. 15% p¼0.01) and this difference was more pronounced in males (60% vs. 16.7%, p¼0.007). Male COM patients were also more likely to be diabetic (22% vs. 0%, p¼0.102). There were no differences in hyperlipidemia, coronary artery disease, gastrointestinal disease, and serum markers of uric acid, calcium, creatinine or HbA1c. COM patients were more likely to have hypocitraturia compared to COD patients (49.3% vs. 25%, p ¼ 0.05). Male COM patients had significantly higher urinary oxalate levels (48 vs. 37 mg/d, p¼0.05) compared to male COD formers. COD females showed a trend towards higher calcium levels vs. COM females (213 vs. 140 mg/d, p¼0.13). The calcium/oxalate ratio in COD formers was significantly higher compared to COM formers (6.46 vs. 4.84, p < 0.05). No differences were observed for urine uric acid levels, supersaturation of uric acid, CaOx supersaturation, magnesium, and pH.
CONCLUSIONS: Our study suggests that HTN and DM, two components of the metabolic syndrome, are more closely linked to COM stones compared to COD stones. Patients with higher urine oxalate and lower urine citrate levels tend to form COM stones, while those with a higher urine calcium/oxalate ratio tend to form COD stones. This suggests that the two stone subtypes are clinically and metabolically different and thus may have different etiology. 
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INTRODUCTION AND OBJECTIVES:
Cystinuria is a rare systemic genetic disease caused by a defect in an amino acid transporter which results in elevated urinary cystine excretion and severe recurrent stone disease. Interestingly, a subset of patients consistently forms stones unilaterally, despite no evidence of anatomic differences between their two kidneys. This study aimed to determine if bilateral cystine stone formers had different clinical outcomes compared to unilateral stone formers and whether thiola use impacted these outcomes.
METHODS: This was a retrospective case-control study for all cystine stone patients evaluated and treated at the University of
